EGF receptor antagonism improves survival in a murine model of pancreatic adenocarcinoma. [electronic resource]
Producer: 20060927Description: 195-201 p. digitalISSN:- 0022-4804
- Adenocarcinoma -- drug therapy
- Animals
- Cell Division -- drug effects
- Cell Line, Tumor
- Disease Models, Animal
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Gene Expression
- Humans
- Mice
- Mice, Nude
- Pancreatic Neoplasms -- drug therapy
- Phenylalanine -- analogs & derivatives
- Protease Inhibitors -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Quinazolines -- pharmacology
- Survival Rate
- Thiophenes -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.